ebomi
Colour theme
Sign in
Insider · CIK 0001592380

Thorp Clay

CIK 0001592380 Name as filed on the most recent filing

Filed as Thorp Clay (37)

87 transaction lines · from 37 filings · filed 2016-06-07 to 2025-02-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

66 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-02-24 P, Open-market purchase Clearside Biomedical, Inc.CLSD 13,800, acquired Open Form 4 filing 0001415889-25-005325
2023-09-25 P, Open-market purchase Clearside Biomedical, Inc.CLSD 8,600, acquired Open Form 4 filing 0001209191-23-050480
2022-12-21 P, Open-market purchase Clearside Biomedical, Inc.CLSD 14,266, acquired Open Form 4 filing 0001209191-22-062338
2022-05-17 P, Open-market purchase Vigil Neuroscience, Inc.VIGL 44,189, acquired Open Form 4 filing 0000899243-22-018491
2022-05-16 P, Open-market purchase Vigil Neuroscience, Inc.VIGL 60,221, acquired Open Form 4 filing 0000899243-22-018491
2022-03-28 P, Open-market purchase Vigil Neuroscience, Inc.VIGL 21,604, acquired Open Form 4 filing 0000899243-22-012485
2022-01-11 P, Open-market purchase Vigil Neuroscience, Inc.VIGL 3,710,000, acquired Open Form 4 filing 0000899243-22-001658
2021-08-18 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 30,000, acquired Open Form 4 filing 0001169245-21-000080
2021-02-10 S, Open-market sale Clearside Biomedical, Inc.CLSD 145,627, disposed Open Form 4 filing 0001209191-22-062044
2021-02-10 S, Open-market sale Clearside Biomedical, Inc.CLSD 145,627, disposed Open Form 4 filing 0001209191-21-010259
2020-11-24 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 7,000, acquired Open Form 4 filing 0001169245-20-000107
2020-11-23 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 11,010, acquired Open Form 4 filing 0001169245-20-000107
2019-07-01 S, Open-market sale PhaseBio Pharmaceuticals IncPHAS 4 lines 40,712, disposed Open Form 4 filing 0001209191-19-041112
2019-06-18 S, Open-market sale PhaseBio Pharmaceuticals IncPHAS 4 lines 5,600, disposed Open Form 4 filing 0001209191-19-038324
2018-12-06 P, Open-market purchase Clearside Biomedical, Inc.CLSD 10,880, acquired Open Form 4 filing 0001209191-18-061355
2018-12-04 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 12,520, acquired Open Form 4 filing 0001209191-18-061125
2018-10-22 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 3 lines 1,500,000, acquired Open Form 4 filing 0001209191-18-056051
2018-05-30 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 38,400,000, disposed Open Form 4 filing 0001209191-18-034839
2018-05-23 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 25,250, disposed Open Form 4 filing 0001209191-18-032789
2018-05-22 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 300,016, disposed Open Form 4 filing 0001209191-18-032789
2018-05-21 S, Open-market sale G1 Therapeutics, Inc.GTHX 4 lines 1,591,411, disposed Open Form 4 filing 0001209191-18-032789
2018-05-18 S, Open-market sale Clearside Biomedical, Inc.CLSD 804,589, disposed Open Form 4 filing 0001209191-18-031802
2018-05-17 S, Open-market sale Clearside Biomedical, Inc.CLSD 1,303,000, disposed Open Form 4 filing 0001209191-18-031802
2018-03-23 S, Open-market sale Clearside Biomedical, Inc.CLSD 62,877, disposed Open Form 4 filing 0001209191-18-021497
2018-03-22 S, Open-market sale Clearside Biomedical, Inc.CLSD 405,914, disposed Open Form 4 filing 0001209191-18-021497
2018-03-21 S, Open-market sale Clearside Biomedical, Inc.CLSD 1,227,000, disposed Open Form 4 filing 0001209191-18-021497
2017-12-07 S, Open-market sale Clearside Biomedical, Inc.CLSD 30,650, disposed Open Form 4 filing 0001209191-17-064491
2017-12-06 S, Open-market sale Clearside Biomedical, Inc.CLSD 91,350, disposed Open Form 4 filing 0001209191-17-064491
2017-12-05 S, Open-market sale Clearside Biomedical, Inc.CLSD 95,550, disposed Open Form 4 filing 0001209191-17-064491
2017-11-16 S, Open-market sale Clearside Biomedical, Inc.CLSD 34,950, disposed Open Form 4 filing 0001209191-17-061256
2017-11-15 S, Open-market sale Clearside Biomedical, Inc.CLSD 104,850, disposed Open Form 4 filing 0001209191-17-061256
2017-11-14 S, Open-market sale Clearside Biomedical, Inc.CLSD 105,300, disposed Open Form 4 filing 0001209191-17-061256
2017-10-05 S, Open-market sale Clearside Biomedical, Inc.CLSD 50,040, disposed Open Form 4 filing 0001209191-17-056207
2017-10-04 S, Open-market sale Clearside Biomedical, Inc.CLSD 120,260, disposed Open Form 4 filing 0001209191-17-056207
2017-10-03 S, Open-market sale Clearside Biomedical, Inc.CLSD 129,600, disposed Open Form 4 filing 0001209191-17-056207
2017-09-15 S, Open-market sale Clearside Biomedical, Inc.CLSD 75,400, disposed Open Form 4 filing 0001209191-17-053020

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 16
  • Open-market sale 50
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Thorp Clay, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001592380

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.